Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

PK1 to enter phase II

March 15, 1996

MEN-10746 selected for development

March 15, 1996

MEN-10755 named as candidate for clinical study

March 15, 1996

Inex reports on liposomal vincristine development

March 15, 1996

Kirin anticancer drug in clinical trials

March 15, 1996

Aminopterin resurrected for ALL

March 15, 1996

University of Bradford reports on cytotoxic indoloquinone

March 15, 1996

Distamycin analogue from P&U shows cytotoxic effects

March 15, 1996

MGI-114 enters phase I

March 15, 1996

Andrulis' platinum-polymer complex

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...